Celltrion Pharm Inc (068760) — Financial Flexibility Index
Celltrion Pharm Inc (068760) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of ₩25.71 Billion (operating CF ₩23.44 Billion minus capex ₩2.27 Billion) represents 0% of total liabilities (₩319.38 Billion). Check 068760 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celltrion Pharm Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Celltrion Pharm Inc across 11 annual periods. See Celltrion Pharm Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Celltrion Pharm Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Celltrion Pharm Inc. For the full company profile including market capitalisation, see 068760 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | ₩62.57 Billion | ₩56.59 Billion | ₩272.54 Billion | ▲ +288.6% |
| 2023 | 0.06x | ₩15.65 Billion | ₩8.76 Billion | ₩264.98 Billion | ▲ +540.8% |
| 2022 | 0.01x | ₩2.24 Billion | ₩-4.05 Billion | ₩242.94 Billion | ▼ -97.3% |
| 2021 | 0.35x | ₩105.65 Billion | ₩93.15 Billion | ₩305.92 Billion | ▲ +9.3% |
| 2020 | 0.32x | ₩78.22 Billion | ₩36.25 Billion | ₩247.51 Billion | ▲ +3.4% |
| 2019 | 0.31x | ₩58.34 Billion | ₩27.85 Billion | ₩190.95 Billion | ▲ +159.0% |
| 2018 | 0.12x | ₩21.52 Billion | ₩14.31 Billion | ₩182.41 Billion | ▲ +329.4% |
| 2017 | -0.05x | ₩-9.08 Billion | ₩-10.16 Billion | ₩176.65 Billion | ▲ +34.7% |
| 2016 | -0.08x | ₩-13.02 Billion | ₩-15.21 Billion | ₩165.37 Billion | ▼ -130.6% |
| 2015 | 0.26x | ₩59.33 Billion | ₩13.36 Billion | ₩230.54 Billion | ▲ +16.4% |
| 2014 | 0.22x | ₩43.48 Billion | ₩17.33 Billion | ₩196.74 Billion | — |